Capricor Therapeutics
CAPR
#5196
Rank
HK$13.09 B
Marketcap
HK$226.16
Share price
-2.40%
Change (1 day)
175.59%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -HK$0.82 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -HK$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -HK$0.83 Billion159.57%
2024 -HK$0.32 Billion81.57%
2023 -HK$0.18 Billion-23.2%
2022 -HK$0.23 Billion44.93%
2021 -HK$0.16 Billion46.61%
2020 -HK$0.11 Billion78.71%
2019 -HK$59.87 Million-49.7%
2018 -HK$0.12 Billion-724.78%
2017 HK$19.04 M-112.93%
2016 -HK$0.15 Billion46.27%
2015 -HK$0.11 Billion106.82%
2014 -HK$48.7 Million-48.41%
2013 -HK$94.4 Million977.23%
2012 -HK$8.77 Million-77.11%
2011 -HK$38.29 Million-22.35%
2010 -HK$49.31 Million-20.17%
2009 -HK$61.76 Million-41.17%
2008 -HK$0.11 Billion41.05%
2007 -HK$74.43 Million1098.87%
2006 -HK$6.21 Million4101.55%
2005 -HK$0.15 Million-0.97%
2004 -HK$0.15 Million17.87%
2003 -HK$0.13 Million3.66%
2002 -HK$0.13 Million-30.11%
2001 -HK$0.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$203.51 B-24,832.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$6.25 B-860.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-HK$6.5 Billion 689.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$2.26 Billion 173.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-HK$37.57 Million-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-HK$74.34 Million-90.97%๐Ÿ‡บ๐Ÿ‡ธ USA